Show results for
Refine by
Conductivity Controller Equipment & Supplies In India
5 equipment items found
Manufactured by:Octostop based inLaval, QUEBEC (CANADA)
Simply place a UNIVERSAL OCTOPAQUE® unit on the four wheels of the OCTOROLL®, and the examination is ready to be conducted from the control bay. Immobilization is safe, efficient and fast. The next baby may even be pre-immobilized outside the room on another OCTOPAQUE®, and brought inside for immediate exchange on the ...
Manufactured by:Gesynta Pharma AB based inStockholm, SWEDEN
GS-248 is Gesynta Pharma’s most advanced drug candidate, currently in clinical development as a potential treatment of systemic sclerosis. Recent clinical phase I data in healthy individuals show that GS-248 potently inhibits the production of PGE2 in a tolerable and safe manner, while increasing the observed levels of protective and vasodilatory prostacyclin by two to three times. The ...
Manufactured by:Emergent BioSolutions Inc. based inGaithersburg, MARYLAND (USA)
Raxibacumab is indicated for the treatment of adult and pediatric patients with inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs. Raxibacumab is also indicated for prophylaxis of inhalational anthrax when alternative therapies are not available or are not ...
Manufactured by:ReGen Therapeutics Limited based inLondon, UNITED KINGDOM
ReGen Therapeutics was formed in February 1998 to develop Colostrinin™, a proline-rich polypeptide complex derived from mammalian colostrum. The complex and the peptides within it are viewed as having potential utility in neurodegenerative illnesses such as Alzheimer’s disease, Parkinson’s Disease, Multiple Sclerosis and Amyotrophic Lateral ...
Manufactured by:MerLion Pharmaceuticals GmbH based inBerlin, GERMANY
Finafloxacin is a novel candidate for the treatment of multiple, life-threatening infection indications, like complicated urinary tract infections (cUTIs). Coming from a well-known and well understood “workhorse” class of antibiotic, its unique properties in activity, safety and flexible dosing regimen options, clearly distinguish finafloxacin from other, existing therapies, offering ...